Inventor · disambiguated record
Joseph R. Pisegna
Also filed as: PISEGNA JOSEPH R
6 granted patents·2 pending applications·7 citations·filing 2000–2021
74Inventor score
Top patents by PatentIndex Score
8 records- 0178US7807623B2Use of pentagastrin to inhibit gastric acid secretion or as a diureticUNIV CALIFORNIA·Filed 2006·Granted Oct 5, 2010·1 cites·8 claims
- 0272US8853356B2Use of pentagastrin to inhibit gastric acid secretion or as a diureticPISEGNA JOSEPH R·Filed 2007·Granted Oct 7, 2014·1 cites·19 claims
- 0367US11186622B2PAC1 receptor agonists (MAXCAPS) and uses thereofUNIV CALIFORNIA·Filed 2018·Granted Nov 30, 2021·1 cites·16 claims
- 0467US7365047B1Use of pentagastrin to inhibit gastric acid secretion or as a diureticUNIV CALIFORNIA·Filed 2000·Granted Apr 29, 2008·4 cites·20 claims
- 0563US12049486B2PAC1 receptor agonists (MAXCAPs) and uses thereofUNIV CALIFORNIA·Filed 2021·Granted Jul 30, 2024·0 cites·16 claims
- 0647US2004110170A1Cloning and characterization of calcitonin gene related peptide receptorsUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 0745US11274303B2Olmalinc as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and hepatic fibrosisUNIV CALIFORNIA·Filed 2018·Granted Mar 15, 2022·0 cites·10 claims
- 0839US2018021319A1Compositions and methods for treating gastrointestinal infectionsUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph R. Pisegna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →